Protective effects of selenomethionine against ionizing radiation under the modulation of p53 tumor suppressor

Journal of Medicinal Food

Volumn 12, Issue 2, 2009, Pages 389-393

  Jeong, Seok Won ^a   Jung, Hwa Jin ^a   Rahman, Md Mujibur ^a   Hwang, Jee Na ^a   Seo, Young R ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Antioxidant; Cancer; Ionizing radiation therapy; Oxidative stress; Selenium

Indexed keywords

PROTEIN P53; REDOX EFFECTOR FACTOR 1; SELENOMETHIONINE; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; DNA REPAIR; DRUG EFFECT; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MICRONUCLEUS; PRIORITY JOURNAL; WILD TYPE;

ANTIOXIDANTS; CELL LINE; CELL LINE, TUMOR; DNA; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FIBROBLASTS; GENE EXPRESSION; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MUTATION; RADIATION, IONIZING; SELENOMETHIONINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67649512558     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0719     Document Type: Article

References (32)

1. Essers J, van Steeg H, de Wit J, et al.: Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J 2000;19:1703-1710.
2. Jung HJ, Kim EH, Mun J-Y, et al.: Base excision DNA repair defect in Gadd45a-deficient cells. Oncogene 2007;26:7517-7525.
3. Seo YR, Kelley MR, Smith ML: Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A 2002;99:14548-14553.
4. Nelson MA, Porterfield BW, Jacobs ET, Clark LC: Selenium and prostate cancer prevention. Semin Urol Oncol 1999;17:91-96.
5. Combs GF Jr, Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 1998;79:179-192.
6. Combs GF: Status of selenium in prostate cancer prevention. Br J Cancer 2004;91:195-199.
7. Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999;20:1657-1666.
8. Whanger PD: Selenium and its relationship to cancer: an update. Br J Nutr 2004;91:11-28.
9. Chang F, Syrjanen S, Syrjanen K: Implications of the p53 tumour-suppressor gene in clinical oncology. J Clin Oncol 1995;13: 1009-1022.
10. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
11. Greenblatt MS, Bennet WP, Hollstein M, et al.: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
12. Gaiddon C, Moorthy NC, Prives C: Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 1999;18:5609-5621.
13. Evans AR, Limp-Foster M, Kelley MR: Going APE over ref-1. Mutat Res 2000;461:83-108.
14. Schwartz TR, Kmiec EB: Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides. BMC Mol Biol 2007;8:7.
15. Ross GM, McMillan TJ, Wilcox P, Collins AR: The single cell microgel electrophoresis assay (comet assay): technical aspects and applications. Mutat Res 1995;337:57-60.
16. Morris DC, Zhang Z, Davies K, Fenstermacher J, Chopp M: High resolution quantitation of microvascular plasma perfusion in non-ischemic and ischemic rat brain by laser-scanning confocal microscopy. Brain Res Protoc 1999;4:185-191.
17. Olive PL, Dyurand RE, Wlodek D, Banath JP: Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Cancer Res 1992;51:4671-4676.
18. Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB: PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 2002;277:5484-5489.
19. Fenech M, Morley AA: Measurement of micronuclei in lymphocytes. Mutat Res 1985;147:29-36.
20. Fenech M, Bonassi S, Turner J, et al.: Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN Project. Mutat Res 2003;534:45-64.
21. Kirsch-Volders M, Sofuni T, Aardema M, et al.: Report from the In Vitro Micronucleus Assay Working Group. Environ Mol Mutagen 2000;35:167-172.
22. Kirsch-Volders M, Sofuni T, Aardema M, et al.: Report from the in vitro micronucleus assay working group. Mutat Res 2003; 540:153-163.
23. Zelefsky MJ, Fuks Z, Hunt M, et al.: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-881.
24. Hanks GE, Hanlon AL, Epstein B, Horwitz EM: Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys 2002;54:427-435.
25. Pollack A, Zagars GK, Starkschall G, et al.: Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-1105.
26. Peters STK, Heemsbergen WD, Van Putten WLJ, et al.: Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61:1019-1034.
27. Safwat A, Bentzen SM, Turesson In Hendry JH: Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:198-204.
28. Tucker SL, Turesson I, Thames HD: Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 1992;28A:1783-1791.
29. Turesson I, Nyman J, Holmberg E, Oden A: Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-1075.
30. Wei SJ, Botero A, Hirota K, et al.: Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 2000;1:6688-6695.
31. Karimpour S, Lou J, Lin LL, et al.: Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 2002;21:6317-6327.
32. Evans HJ, Neary GJ, Williamson FS: The relative biological efficiency of single doses of fast neutrons and gamma rays in Vicia faba roots and the effect of oxygen. Int J Radiat Biol 1959;1:230-240.